Side-by-side comparison of AI visibility scores, market position, and capabilities
European fintech super-app with 45M users and £2.2B 2023 revenue; UK banking license received 2024, $45B valuation, and expected IPO in 2025-2026.
Revolut is a UK-based global financial super-app offering banking, international money transfers, currency exchange, cryptocurrency trading, stock investing, and insurance through a single mobile application. Founded in 2015 by Nikolay Storonsky and Vlad Yatsenko, Revolut has grown into Europe's most valuable privately held fintech company with a $45 billion valuation set by a 2024 secondary transaction. The company received its UK banking license in July 2024 after a years-long regulatory process, marking a critical milestone in its evolution from a prepaid card to a full bank.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.